“Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?” (2020) Brazilian Journal of Pharmaceutical Sciences, 56, p. e18309 . doi:10.1590/s2175-97902020000218309.